Stefan Zielonka, PhDAssociate Director at Merck KGaA/EMD Serono
Stefan received his PhD in 2015 from the Technische Universität of Darmstadt, Germany, where he worked in
the Group of Harald Kolmar in the field of protein engineering of non-canonical antibodies. At the moment he
works as Principal Scientist / Group Leader at Merck KGaA (EMD Serono), Germany, in the Department Protein
Engineering and Antibody Technologies (PEAT).